vs
Ategrity Specialty Insurance Co Holdings（ASIC）与Axsome Therapeutics, Inc.（AXSM）财务数据对比。点击上方公司名可切换其他公司
Axsome Therapeutics, Inc.的季度营收约是Ategrity Specialty Insurance Co Holdings的1.6倍（$191.2M vs $116.1M）
Ategrity Specialty Insurance Co Holdings是一家特种保险控股企业，提供商业财产及意外伤害保险解决方案，主营超额与盈余线保险业务，服务美国本土建筑、医疗、小型企业等细分领域，为标准保险公司通常不承接的特殊风险提供定制化保单。
Jazz Pharmaceuticals是一家全球生物制药企业，专注于肿瘤学与神经科学领域的药物研发及商业化。公司2003年在美国加利福尼亚州成立，目前总部位于爱尔兰都柏林，业务覆盖全球多个核心市场。
ASIC vs AXSM — 直观对比
营收规模更大
AXSM
是对方的1.6倍
$116.1M
损益表 — Q3 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $116.1M | $191.2M |
| 净利润 | $22.7M | — |
| 毛利率 | — | — |
| 营业利润率 | 25.6% | -33.1% |
| 净利率 | 19.5% | — |
| 营收同比 | — | 57.4% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $0.45 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASICAXSM
| Q1 26 | — | $191.2M | ||
| Q4 25 | — | $196.0M | ||
| Q3 25 | $116.1M | $171.0M | ||
| Q2 25 | $101.8M | $150.0M | ||
| Q1 25 | — | $121.5M | ||
| Q4 24 | — | $118.8M | ||
| Q3 24 | — | $104.8M | ||
| Q2 24 | — | $87.2M |
净利润ASICAXSM
| Q1 26 | — | — | ||
| Q4 25 | — | $-28.6M | ||
| Q3 25 | $22.7M | $-47.2M | ||
| Q2 25 | $17.6M | $-48.0M | ||
| Q1 25 | — | $-59.4M | ||
| Q4 24 | — | $-74.9M | ||
| Q3 24 | — | $-64.6M | ||
| Q2 24 | — | $-79.3M |
营业利润率ASICAXSM
| Q1 26 | — | -33.1% | ||
| Q4 25 | — | -13.8% | ||
| Q3 25 | 25.6% | -27.0% | ||
| Q2 25 | 21.9% | -24.5% | ||
| Q1 25 | — | -46.9% | ||
| Q4 24 | — | -61.1% | ||
| Q3 24 | — | -59.8% | ||
| Q2 24 | — | -89.5% |
净利率ASICAXSM
| Q1 26 | — | — | ||
| Q4 25 | — | -14.6% | ||
| Q3 25 | 19.5% | -27.6% | ||
| Q2 25 | 17.3% | -32.0% | ||
| Q1 25 | — | -48.9% | ||
| Q4 24 | — | -63.1% | ||
| Q3 24 | — | -61.7% | ||
| Q2 24 | — | -91.0% |
每股收益（稀释后）ASICAXSM
| Q1 26 | — | — | ||
| Q4 25 | — | $-0.55 | ||
| Q3 25 | $0.45 | $-0.94 | ||
| Q2 25 | $0.39 | $-0.97 | ||
| Q1 25 | — | $-1.22 | ||
| Q4 24 | — | $-1.54 | ||
| Q3 24 | — | $-1.34 | ||
| Q2 24 | — | $-1.67 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $34.3M | $305.1M |
| 总债务越低越好 | — | $70.0M |
| 股东权益账面价值 | $588.6M | — |
| 总资产 | $1.4B | $713.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASICAXSM
| Q1 26 | — | $305.1M | ||
| Q4 25 | — | $322.9M | ||
| Q3 25 | $34.3M | $325.3M | ||
| Q2 25 | $23.5M | $303.0M | ||
| Q1 25 | — | $300.9M | ||
| Q4 24 | — | $315.4M | ||
| Q3 24 | — | $327.3M | ||
| Q2 24 | — | $315.7M |
总债务ASICAXSM
| Q1 26 | — | $70.0M | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益ASICAXSM
| Q1 26 | — | — | ||
| Q4 25 | — | $88.3M | ||
| Q3 25 | $588.6M | $73.7M | ||
| Q2 25 | $559.7M | $73.1M | ||
| Q1 25 | — | $53.2M | ||
| Q4 24 | — | $57.0M | ||
| Q3 24 | — | $92.9M | ||
| Q2 24 | — | $102.9M |
总资产ASICAXSM
| Q1 26 | — | $713.6M | ||
| Q4 25 | — | $689.8M | ||
| Q3 25 | $1.4B | $669.3M | ||
| Q2 25 | $1.4B | $639.8M | ||
| Q1 25 | — | $596.7M | ||
| Q4 24 | — | $568.5M | ||
| Q3 24 | — | $561.5M | ||
| Q2 24 | — | $548.2M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $41.1M | — |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 1.81× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ASICAXSM
| Q1 26 | — | — | ||
| Q4 25 | — | $-18.7M | ||
| Q3 25 | $41.1M | $1.0M | ||
| Q2 25 | $50.8M | $-32.4M | ||
| Q1 25 | — | $-43.4M | ||
| Q4 24 | — | $-26.2M | ||
| Q3 24 | — | $-18.6M | ||
| Q2 24 | — | $-30.1M |
自由现金流ASICAXSM
| Q1 26 | — | — | ||
| Q4 25 | — | $-18.7M | ||
| Q3 25 | — | $988.0K | ||
| Q2 25 | — | $-32.4M | ||
| Q1 25 | — | $-43.7M | ||
| Q4 24 | — | $-26.2M | ||
| Q3 24 | — | $-18.7M | ||
| Q2 24 | — | $-30.2M |
自由现金流率ASICAXSM
| Q1 26 | — | — | ||
| Q4 25 | — | -9.6% | ||
| Q3 25 | — | 0.6% | ||
| Q2 25 | — | -21.6% | ||
| Q1 25 | — | -36.0% | ||
| Q4 24 | — | -22.1% | ||
| Q3 24 | — | -17.9% | ||
| Q2 24 | — | -34.6% |
资本支出强度ASICAXSM
| Q1 26 | — | — | ||
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.3% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.1% | ||
| Q2 24 | — | 0.1% |
现金转化率ASICAXSM
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 1.81× | — | ||
| Q2 25 | 2.88× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASIC
暂无分部数据
AXSM
| Product sales, net | $189.4M | 99% |
| Royalty revenue and milestone revenue | $1.8M | 1% |
